a.k.a. Brands AKA 深 沪
等待开盘 07-25 09:30:00 美东时间
10.97
-0.030
-0.27%
华盛通- 最 高10.97
- 今 开10.18
- 成交量 2154股
- 最 低 10.18
- 昨 收 11.00
- 总市值 1.19亿
- 52周最高 16.38
- 市盈率 静 --
- 换手率 0.02%
- 52周最低 8.42
- 委 比 -2.44%
- 总股本 1082.21万
- 历史最高 182.76
- 量 比 0.80
- 振 幅 7.18%
- 历史最低 3.60
- 每 手 1
- 风险率 1.22%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多a.k.a. Brands Holding shares are trading higher after the company reported better-than-expected Q1 financial results.
a.k.a. Brands Holding shares are trading higher after the company reported bett...
05-13 04:21
a.k.a. Brands Holding Sees Q2 Sales $160.000M-$164.000M vs $164.628M Est
a.k.a. Brands Holding (NYSE:AKA) sees Q2 sales of $160.000 million-$164.000 million vs $164.628 million analyst estimate.
05-13 04:09
a.k.a. Brands Holding Q1 EPS $(0.66) Beats $(1.00) Estimate, Sales $132.464M Beat $131.170M Estimate
a.k.a. Brands Holding (NYSE:AKA) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(1.00) by 34 percent. This is a 15.38 percent increase over losses of $(0.78) per share from
05-13 04:08
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
美股大行评级 | Stifel上调Lumentum控股目标价从800美元升至1100美元；Pinterest、先进能源工业、安森美半导体、莱迪思半导体、V2X等获多家大行上调目标价
今日重点评级关注：Piper Sandler：维持Aclaris Therapeutics"超配"评级，目标价从7美元升至11美元；Evercore ISI集团：维持BioMarin Pharmaceutical"跑赢大市"评级，目标价从110美元升至120美元
05-06 11:29
Small Cap Consumer Research Reiterates Buy on a.k.a. Brands Holding, Maintains $30 Price Target
Small Cap Consumer Research analyst Eric M Beder reiterates a.k.a. Brands Holding (NYSE:AKA) with a Buy and maintains $30 price target.
05-05 20:04
A.k.a. Brands Introduces Petal & Pup's Global Evergreen Brand Campaign
A.k.a. Brands Holding Corp. (NYSE: AKA), a portfolio of next generation fashion brands, today announces the launch of Petal & Pup's global evergreen brand campaign and the official debut of the brand's evolved
03-13 21:03
美股大行评级 | 潜在涨幅183%！迈威尔科技获10家机构上调目标价最高至164美元；伯灵顿百货、好市多、Ciena、Samsara等获多家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持BridgeBio Oncology"买入"评级，目标价从27美元升至29美元；韦德布什：维持WAVE Life Sciences"跑赢大市"评级，目标价从33美元升至35美元
03-09 11:47
Earnings Scheduled For March 5, 2026
Companies Reporting Before The Bell • Palladyne AI (NASDAQ:PDYN) is projected t...
03-05 19:11
